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Gut granules are lysosome-like organelles with acidic interiors that are found in large
numbers within the intestine of the nematodeCaenorhabditis elegans.They are particularly
prominent when viewed under ultraviolet light, which causes them to emit intense blue
ﬂuorescence.Yet the function of these large and abundant organelles in this heavily-studied
model organism remains unclear. One possibility is that they serve as storage organelles,
for example of zinc. A new clue to gut granule function is the identiﬁcation of the blue
ﬂuorescent material that they contain as a glycosylated form of anthranilic acid, which is
derived from tryptophan by action of the kynurenine pathway. This compound can also
serve a surprising role as a natural, endogenous marker of organismal death.
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THE GUT GRANULE: AN ENIGMATIC NEMATODE ORGANELLE
Despite decades of research on the nematode Caenorhabditis
elegans, it still contains many hidden secrets. One such is the func-
tion of the prominent organelles known as gut granules, which
are numerous in the intestinal cells of nematodes throughout the
suborder Rhabditina (Chitwood and Chitwood, 1950). A strik-
ing feature of gut granules is the blue ﬂuorescence that they emit
under ultraviolet light (Klass, 1977; Gerstbrein et al., 2005). Clues
to gut granule function include their acidic interior and capac-
ity for endocytosis (Clokey and Jacobson, 1986; Hermann et al.,
2005), both lysosome-like features (though gut granules are much
bigger than normal lysosomes). This and the ﬂuorescent material
within identify gut granules as lysosome-like organelles (LROs;
Hermann et al., 2005; Bernabucci et al., 2012), akin to pigment-
containing melanosomes in mammals and eye pigment granules
in Drosophila (Raposo and Marks, 2007). Thus, the identity of the
blue ﬂuorescent substance could provide a key to understanding
gut granule function.
One suggestion is that the source of gut granule ﬂuorescence is
lipofuscin, a complex molecular waste production that accumu-
lateswithin lysosomes in agingmammalian cells (Jung et al., 2007).
Lipofuscin can contain Schiff bases, which have similar spectral
similarities to the worm blue ﬂuorescence (Fletcher et al., 1973;
Klass, 1977). Consistent with this, blue ﬂuorescence levels increase
in aging worm populations (Klass, 1977; Davis et al., 1982; Gerst-
brein et al., 2005). Another idea, derived from studies of C. elegans
Flu mutants with altered ﬂuorescence color and intensity, is
that the blue ﬂuorescence emanates from L-tryptophan-derived
metabolites called kynurenines (Babu, 1974).
Over the years the lipofuscin interpretation has been favored
(see e.g., Gill, 2006; Masse et al., 2008; Fujii et al., 2009; Jain et al.,
2009; Minniti et al., 2009), perhaps because of the good ﬁt with the
theory that aging is caused by accumulation of molecular damage.
Unfortunately, this interpretation (i.e., that the blue ﬂuorescent
substance is lipofuscin) is not the correct one. According to recent
chemical analysis, the ﬂuorescent substance within gut granules
is a kynurenine pathway product, anthranilic acid (AA) glucosyl
ester (Coburn et al., 2013), consistent with the proposal of P. Babu
and S. S. Siddiqui so many years ago (Babu, 1974; Bhat and Babu,
1980; Siddiqui and Babu, 1980). This chemical identiﬁcation was
effected by comparingwild-type wormswith glo-1mutants, which
lack gut granules (Hermann et al., 2005). Whether or not lipofus-
cin exists in C. elegans remains an open question. Thus, C. elegans
gut granules contain large quantities of AA. But what it is there
for? Here, one may seek clues from kynurenine pathway action in
mammals.
THE KYNURENINE PATHWAY AND NEURODEGENERATION
In mammals, the kynurenine pathway generates a variety of
important molecules, including the co-factor nicotine adenine
dinucleotide (NAD) and the neurotransmitter serotonin. Around
95% of tryptophan (the rarest essential amino acid) is consumed
by this pathway (Vecsei et al., 2013). Although discovered over
150 years ago, the action of the kynurenine pathway’s inter-
mediate metabolites, known as kynurenines, has until recently
been relatively little studied (Schwarcz et al., 2012). One role
of kynurenines is in modulating CNS excitability (Perkins and
Stone, 1982; Hilmas et al., 2001; Vecsei et al., 2013). For example,
the kynurenine quinolinic acid stimulates N-methyl-D-aspartate
(NMDA) receptors (Stone and Perkins, 1981; Schwarcz et al.,
2012), while kynurenic acid antagonizes all excitatory amino acid
receptors.
Kynurenine pathway dysregulation has been implicated in
neurological disorders, including Huntington’s, Alzheimer’s, and
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Parkinson’s disease, multiple sclerosis, and epilepsy (Vecsei et al.,
2013) as well as in neurodegeneration caused by acute insults,
such as ischemia and excitotoxicity (Stone et al., 2012). Excito-
toxic neurodegeneration is caused by release of high levels of
excitatory neurotransmitters, which trigger an inﬂux of calcium
ions after depolarization (Rothman and Olney, 1987). Thus, cal-
cium can act as a second messenger, triggering the initiation of
necrotic cell death (Rothman and Olney, 1995). The kynurenine
quinolinic acid can act as an excitotoxin: levels increase following
ischemia, and correlate with increased neurodegeneration (Saito
et al., 1993). Thus, one of the ways in which kynurenines may
contribute to neurodegenerative disease is by inducing excitotoxic
neurodegeneration.
THE KYNURENINE PATHWAY IN C. elegans
Is there a link between kynurenines and aging, particularly neu-
rodegeneration, in C. elegans? Very little is known about the
biology of kynurenines in nematodes. One exception relates back
to gut granules: among the Flu mutants alluded to previously,
altered intestinal ﬂuorescence (Flu) phenotypes can arise from
mutations affecting kynurenine pathway enzymes. For example,
ﬂu-1 mutants, which show an altered, bluish-purple gut granule
ﬂuorescence, have reduced kynurenine-3-hydroxylase activity
(Siddiqui and Babu, 1980), and ﬂu-2 mutants, which show a dull
green ﬂuorescence, have reduced kynureninase (Bhat and Babu,
1980; Figure 1A). The C. elegans genome contains homologs of
genes encoding these two enzymes in the vicinity of the ﬂu-1 and
ﬂu-2 loci: a kynurenine hydroxylase, R07B7.5, and a kynureni-
nase C15H9.7, respectively (Altschul et al., 1990; Kanehisa, 2012).
Other predicted kynurenine pathway genes are also present in C.
elegans (van der Goot and Nollen, 2013).
In Drosophila genetic and pharmacological inhibition of the
kynurenine pathway enzyme tryptophan 2,3-dioxygenase (TDO)
extends longevity (Oxenkrug, 2010; Oxenkrug et al., 2011). This
suggests that kynurenines may contribute to pathologies of aging;
however, whether this is true in C. elegans remains uncer-
tain. Here RNAi knock-down of tdo-2 reduced the toxicity of
α-synuclein aggregation in a Parkinson’s disease model, and
increased lifespan (van der Goot et al., 2012). However, these
effects proved to be caused by increased levels of tryptophan
rather than altered levels of kynurenines (van der Goot et al.,
2012; for a detailed review of the kynurenine pathway and aging
FIGURE 1 | (A) Synthesis of anthranilic acid by the kynurenine pathway.
(B) Death ﬂuorescence in young adult C. elegans killed with a heated wire
(DAPI ﬁlter). During death ﬂuorescence the pattern of ﬂuorescence changes
from punctate (issuing from gut granules) to diffuse, and much brighter. A, P,
anterior and posterior ends of intestine. Time is relative to peak ﬂuorescence.
Scale bar, 200 μm.
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see van der Goot and Nollen, 2013). tdo-2RNAi also abrogates gut
granule ﬂuorescence in the worm (Coburn et al., 2013).
Kynurenines also play a startling role in the biology of death
in C. elegans. As they die, worms emit a dramatic burst of blue
AA ﬂuorescence (Coburn et al., 2013; Figure 1B). This death
ﬂuorescence typically occurs in an anterior to posterior wave that
courses along the intestine, and is seen in both young worms sub-
jected to lethal injury, and worms dying peacefully of old age.
Death ﬂuorescence is a somewhat eerie phenomenon in that it
renders visible the passage of death through the semi-transparent
body of the worm as a spectral blue glow.
Death ﬂuorescence is promoted by the calpain–cathepsin
necrotic cell death cascade. In this cascade, intracellular Ca2+ lev-
els rise, activating Ca2+-dependent calpains (cysteine proteases;
Yamashima et al., 1996). These cause lysosomal lysis, leading
to cytosolic acidosis and the destructive release of lysosomal
cathepsin proteases (Yamashima and Oikawa, 2009). Mutational
attenuation of this cascade often reduces death ﬂuorescence
(Coburn et al., 2013). Moreover, the intercellular propagation of
death ﬂuorescence (and, probably, necrosis) is dependent upon
the innexin gap junction INX-16, reminiscent of the spread of
excitotoxic neuronal death from one cell to another in mammals.
How exactly the necrotic cascade leads to increased AA ﬂuores-
cence remains unclear, but one possibility is that it reﬂects AA
ﬂuorescence dequenching as it is released from the gut granules
upon organellar lysis.
POSSIBLE FUNCTIONS OF ANTHRANILATES AND GUT
GRANULES IN C. elegans
The signiﬁcance of AA concentrated within gut granules remains
unclear. One possibility is that glycosylation of AA contributes
to its accumulation; in Arabidopsis, glycosylation by UDP-
glucosyltransferases promotes AA accumulation by increasing
compound stability (Quiel and Bender, 2003). Regarding func-
tion, one possibility is thatAA serves a protective role. Inmammals
kynurenines can contribute to immune function (Munn et al.,
1998; Fallarino et al., 2002; Piscianz et al., 2011). Moreover, AA
can inhibit growth of bacterial pathogens, e.g., Legionella pneu-
mophila (Sasaki et al., 2012). Thus, AA might have antibiotic
properties in C. elegans, in which case gut granules could serve as a
store of anti-bacterial agents in the event of pathogen attack. This
suggests a broader role for gut granules: that of chemical weapons
depots for C. elegans in their war against the diverse pathogens
that beset them in their natural environment (Felix and Braendle,
2010). This could also explain the presence of gut granules in the
intestine, the site most likely to experience pathogenic invasion
in C. elegans (Hodgkin and Partridge, 2008). Another possibility,
suggested by similarities between gut granules and melanosomes,
is that they are photoprotective. AA ﬂuorescence (peak λex/λem
340 nm/430 nm) entails the conversion of damaging UV light to
relatively harmless visible light, and so may protect against UV
damage.
The large size of gut granules relative to ordinary lysosomes
is consistent with function as a storage organelle. Moreover, gut
granules are the major site of storage of zinc in the worm (Roh
et al., 2012). Interestingly, when zinc levels are high, gut granule
morphology changes, becoming bilobed, including an apparently
non-acidic compartment in which zinc is concentrated. How
distribution of zinc and AA compares in such bilobed gut gran-
ules remains to be established. It is also notable that both metal
toxicity and kynurenines are determinants of neurodegenerative
disease. Gut granules also stainwith the lipid staining vital dyeNile
red; however, results of careful analysis imply that this does not
reﬂect the presence of lipid within gut granules (O’Rourke et al.,
2009).
Ultimately, the role in C. elegans biology of gut granules and
the AAs they contain remains obscure and a topic for future inves-
tigation. But we now know at least that the ﬂuorescence of these
prominent organelles issues from AA glucosyl esters, rather than
lipofuscin – removing one reason for believing that worm aging
is caused by accumulation of molecular damage, and opening the
way for alternatively theories (Gems and de la Guardia, 2012). And
we know that gut granule decay contributes to a wave of intestinal
necrosis accompanied by a burst of blue anthranilate ﬂuorescence,
which serves as a useful marker for organismal death in C. elegans.
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